Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Nemunaitis

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Expert Review of Vaccines|July 20, 2005
Vaccines in cancer: GVAX, a GM-CSF gene vaccineJohn Nemunaitis
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2003
Selective replicating viral vectors : potential for use in cancer gene therapyJohn Nemunaitis
Oncology (Williston Park, N.Y.)|December 10, 2002
Live viruses in cancer treatmentJohn Nemunaitis
Expert Opinion on Therapeutic Targets|June 13, 2012
Stathmin 1: a protein with many tasks. New biomarker and potential target in cancerJohn Nemunaitis
Expert Review of Vaccines|June 23, 2011
Multifunctional vaccines in cancer: the 'triad' approachJohn Nemunaitis
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2003
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancerJohn Nemunaitis
Human Vaccines & Immunotherapeutics|February 28, 2013
Cancer targeting vaccines: surrogate measures of activityJohn Nemunaitis
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Immune-modulating vaccines in non-small cell lung cancerJohn Nemunaitis, Nevin Murray
Head & Neck|March 12, 2010
Head and neck cancer: response to p53-based therapeuticsJackie Nemunaitis, John Nemunaitis
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
GM-CSF gene-transduced tumor vaccinesRobert Eager, John Nemunaitis
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Expert Review of Vaccines|July 20, 2005
Vaccines in cancer: GVAX, a GM-CSF gene vaccineJohn Nemunaitis
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2003
Selective replicating viral vectors : potential for use in cancer gene therapyJohn Nemunaitis
Oncology (Williston Park, N.Y.)|December 10, 2002
Live viruses in cancer treatmentJohn Nemunaitis
Expert Opinion on Therapeutic Targets|June 13, 2012
Stathmin 1: a protein with many tasks. New biomarker and potential target in cancerJohn Nemunaitis
Expert Review of Vaccines|June 23, 2011
Multifunctional vaccines in cancer: the 'triad' approachJohn Nemunaitis
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2003
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancerJohn Nemunaitis
Human Vaccines & Immunotherapeutics|February 28, 2013
Cancer targeting vaccines: surrogate measures of activityJohn Nemunaitis
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Immune-modulating vaccines in non-small cell lung cancerJohn Nemunaitis, Nevin Murray
Head & Neck|March 12, 2010
Head and neck cancer: response to p53-based therapeuticsJackie Nemunaitis, John Nemunaitis
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
GM-CSF gene-transduced tumor vaccinesRobert Eager, John Nemunaitis
Pageof 20